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Functional characterization of drug-induced experimental papil-
lary necrosis. The functional expression of papillary necrosis was
investigated with a model of drug-induced papillary necrosis.
Bromoethylamine hydrobromide (BEA) administration to rats
uniformly resulted in the development of papillary necrosis. All
studies were performed 24 hours after BEA administration with
the exception of the electrolyte balance studies, which were per-
formed during the 72 hours after the induction of papillary necro-
sis. GFR was not different between BEA-treated and sham rats.
BEA-treated rats had a significantly lower maximal urine Os-
molality and free water reabsorption than did sham rats. Renal
tissue concentrations of sodium, potassium, and water were not
different between BEA-treated and sham rats. During water di-
uresis, free water clearance was not significantly different be-
tween the two groups. During sodium bicarbonate administra-
tion, maximal bicarbonate reabsorption and urine-blood Pco2
gradient (at comparable urine bicarbonate Concentrations) were
not significantly different between the two groups. During so-
dium sulfate infusion, there was no difference in minimum urine
pH, ammonium excretion, and net acid excretion between
chronically acidotic BEA-injected and sham rats. In rats on "ze-
ro' sodium intake, BEA administration resulted in a significant
increase in urine flow and sodium excretion, whereas sham rats
remained in sodium balance. In rats with restriction of both so-
dium and chloride, BEA administration resulted in a significant
wastage of sodium, chloride, and calcium. There was no dif-
ference in potassium excretion between BEA-treated and sham
rats during hydropenia, bicarbonate administration, sodium sul-
fate infusion, or ingestion of a normal potassium diet. When po-
tassium intake was restricted to "zero,' BEA-treated rats devel-
oped potassium wastage; when potassium intake was increased
to 21 mEq/day, BEA-treated rats had a significantly lower potas-
sium excretion than did sham rats. These findings may result
from alterations in collecting duct transport, but damage to deep
medullary structures may also contribute.
Caracteristiques fonctionnelles de Ia nécrose papillaire ex-
périmentale d'origine médicamenteuse. U expression fonction-
nelle de Ia nécrose papillaire a etC Ctudiée au moyen dun mod-
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Cle experimental. L'administration d'hydrobromide de bromo-
ethylamine (BEA) a des rats a pour consequence constante le
dCveloppement dune nCcrose papillaire. Toutes les etudes ont
dté rCalisées 24 heures après l'administration de BEA, a
l'exception des bilans Clectrolytiques qui ont etC conduits 72
heures après l'induction de Ia nCcrose papillaire. Le GFR n'est
pas modifiC chez les animaux traitCs, par comparison avec les
contrôles. Les rats traitds ont une osmolalitC urinaire maximale
et une reabsorption d'eau libre significativement abaissées. Les
concentrations tissulaires rCnales de sodium, potassium, et d'eau
ne sont pas diffCrentes. Au cours de Ia diurCse aqueuse l'ex-
crétion d'eau libre nest pas différente. Au cours de l'admini-
stration de sodium bicarbonate, Ia reabsorption maximale de
bicarbonate et le gradient urine-sang de Pco2 (a concentra-
tions urinaires comparables de bicarbonate) ne sont pas signifi-
cativement diffCrents entre les deux groupes. 11 ny a pas de dif-
fCrence de pH minimal de l'urine, d'excrCtion de ammonium ou
d'excrCtion nette dacide au cours de l'administration de sodium
sulfate entre les rats en acidose chronique BEA et contrôles.
Chez les rats en restriction de sodium l'administration de BEA a
pour consequence une augmentation significative du debit un-
naire et de l'excrétion de sodium alors que les contrôles restent
en bilan nul de sodium. Chez les rats en restriction de sodium et
chloride, I'administration de BEA a pour consequence une perte
significative de sodium, chloride, et calcium. Il n'y a pas de dif-
férence significative dans l'excrétion de potassium entre les rats
BEA et les contrOles au cours de l'hydropenie, de l'admini-
stration de bicarbonate, de Ia perfusion de sodium sulfate ou
au cours de l'ingestion d'un régime normal en potassium.
Quand l'apport de potassium est restreint a zero, les rats BEA
ont une perte de potassium et quand il est augmente a 21 mEq/
jour les rats BEA ont une excretion significativement infCrieure
a celle des contrôles. Ces constatations peuvent être Ia con-
sequence de modifications des transports dans les canaux collec-
teurs, mais les lesions des structures mCdullaires profondes
peuvent aussi contribuer a ces rCsultats.
Bromoethylamine hydrobromide (B EA) adminis-
tration to rats results in the development of papil-
lary necrosis in virtually 100% of animals. Murray
et al [1] and Hill et a! 2j have described in detail the
pathologic findings of BEA-induced papillary ne-
crosis. Twenty-four hours after the administration
of BEA, the thin limbs and collecting ducts in the
papilla showed eosinophic changes in the cytoplasm
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and occasionally in the lumen. At 48 hours there
was complete necrosis of the thin limbs, and the
collecting ducts were affected then more severely
with eosinophic droplets in the lumen. Complete
papillary necrosis was evident between days 4 and
7. These changes were mainly evident in the papilla,
whereas the outer and inner stripes of the medulla
were unaffected. Focal mitotic changes were seen
also in the proximal tubules, particularly in the
proximal tubules of juxtamedullary nephrons.
These observations suggested to us that the BEA
model of papillary necrosis would be a very inter-
esting model in which to examine the effect of this
lesion on electrolyte transport.
This experimental model of papillary necrosis al-
lows a systematic evaluation of the role of papillary
structures on overall renal function and thus should
provide new insights on the functional abnormal-
ities of the human counterpart of papillary necrosis.
Accordingly, we used the BEA model of papillary
necrosis to study electrolyte transport under a vari-
ety of experimental settings.
Methods
Rats were anesthetized i.p. with mactin (10 mgI
100 g of body wt; Promonta, Hamburg, West Ger-
many). Tracheostomy was performed, and one ca-
rotid artery and jugular vein were cannulated. The
bladder was catheterized through an abdominal in-
cision. Blood pressure was monitored throughout
the experiment. At the start of the experiment, J125
iothalamate diluted in saline (0.75 jsCi/ml) was in-
fused by an infusion pump at a rate of 0.024 mllmin
throughout the course of the experiment as a mark-
er of GFR. An equilibration period of 60 mm was
allowed before any collections were started. Urine
samples were collected under mineral oil in pre-
weighed glass vials, and the urine volume was de-
termined gravimetrically. Blood samples were col-
lected from the carotid artery during the rnidportion
of each clearance collection; collections were of 10
to 20 mm's duration.
Twenty-four hours preceding the clearance stud-
ies, the rats were injected i.v., under anesthesia, ei-
ther with 50 mg of BEA diluted in I ml of 0.9% so-
dium chloride or with 1 ml of 0.9% sodium chloride
(sham rats).
Group 1: Hydropenic rats. Ten BEA-treated rats
and six control rats were prepared for clearance
study as described above. Two clearance collec-
tions were obtained.
Group 2: Bicarbonate reabsorption. After two
control collections, five BEA-treated rats and five
sham rats were infused with 0.9 M sodium bicarbo-
nate at a rate of 4 to 6 mL/hr to produce stepwise in-
crements in plasma bicarbonate from normal levels
up to 45 to 50 mEq/liter. Four to five clearance col-
lections were obtained during sodium bicarbonate
infusion.
Group 3: Chronic ammonium chloride adminis-
tration + sodium sulfate infusion. Twelve rats were
given 1.5% ammonium chloride as drinking fluid for
at least 4 days preceding the study. Twenty-four
hours preceding the study, six rats were injected
with BEA, and six rats were injected with 0.9%
sodium chloride. Deoxycorticosterone acetate
(DOCA) was administered i.m. at a dose of 1.5 mg,
24 and 2 hours before the study. After baseline
blood and urine collections were made, we infused
BEA-treated and sham rats with 4% sodium sulfate
at a rate of 0.04 mllmin for 60 to 90 mm; two to three
collections were obtained during sodium sulfate in-
fusion.
Group 4: Maximal urine osmolality. Five BEA-
treated rats and five sham rats were injected s.c.
with 1 U of Pitressin® tannate in oil (Parke Davis
Corporation) 18 and 2 hours before the urine was
collected (morning samples); food and water were
restricted for 18 hours. An additional four BEA-
treated rats were treated with Pitressin® in the same
way as above, but fluid was not restricted.
Group 5: Free water reabsorption (TCHZO). Four
BEA-treated rats were infused with 3% sodium
chloride at progressively increasing rates, from 0.1
to I mllmin, in a period of approximately 3 hours to
increase osmolar clearance. Water was withheld 18
hours prior to the study, at which time all animals
received s.c. 1 U of Pitressin® tannate in oil. Aque-
ous Pitressin® was infused continuously at a rate of
20 mU/hr. Five clearance collections were ob-
tained. Free water reabsorption was also measured
in six BEA-treated and five sham rats undergoing
0.9 M sodium bicarbonate infusion (group 2).
Group 6: Renal tissue solute concentration. Ten
BEA-treated and eight sham rats were deprived of
water for 18 hours and were killed; kidneys were
then removed, weighed, and cut longitudinally. At
24 hours after BEA administration, the cortex, the
medulla, and papillary structures were clearly iden-
tifiable, and no difficulty in separating these struc-
tures was found. The entire papilla and parts of both
the medulla and cortex were removed and weighed.
Part of the tissue from each section was used for
determination of water content, and the remainder
was used for measurement of sodium and potas-
sium. The tissue was dried in an oven for 48 hours
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at 800 C, and the free water content was taken as
the difference between the wet weight and dry
weight. For determination of solute concentration,
the samples were homogenized in 500 d of distilled
water, centrifuged at 40 C for 20 mm at x800g, and
the supernatant was removed and analyzed for so-
dium and potassium.
Group 7: Free water clearance. Five BEA-
treated and five sham rats were included in this
group. For each group, water diuresis was induced
by administering an oral load of solution containing
0.225% saline and 1.5% glucose in an amount equiv-
alent to 8% body weight. A steady state of water
diuresis was subsequently maintained by i.v. in-
fusion of 0.225% saline in an amount equal to the
urine flow. An equilibration period of 60 mm was
allowed before any collections were started. The
experiment was begun when urine osmolality was
lower than 120 mOsm. Two to three clearance col-
lections were obtained.
Group 8: Sodium restriction. Eleven normal rats
were fed lOg/day of a 'zero" sodium diet (see com-
position below). The rats were kept in individual
metabolic cages to allow 24-hour urine collections.
After they underwent an equilibration period of at
least 5 days on this diet, we collected 24-hour urine
samples from them for three consecutive days. In
the morning of day 4, five rats were injected with
BEA, and the remaining six rats were injected with
0.9% sodium chloride. Three additional 24-hour
urine collections were then obtained. At the end
of the study, the animals were exsanguinated
through the abdominal aorta, and blood pH, Pco2,
plasma electrolyte concentrations, and PRA were
measured.
Group 9: Sodium chloride restriction. Eleven
normal rats were fed 10 g/day of a "zero" sodium,
chloride, and potassium diet (see composition be-
low). Potassium phosphate was added to the diet in
an amount of 2 mEq of potassium per 10 g of diet.
The rats were studied then exactly as in the pre-
vious groups. Five rats were injected with BEA and
six rats with 0.9% sodium chloride.
Group 10: Potassium restriction. Ten normal rats
were fed 10 g/day of a "zero" potassium diet (see
composition below). After they underwent an equil-
ibration period of at least 5 days on this diet, we
obtained 24-hour urine collections from them during
3 consecutive days. On day 4, five animals were in-
jected with BEA and five with 0.9% sodium chlo-
ride. Three additional 24-hour urine collections
were obtained. For the duration of the study, both
groups of rats were given 0.45% sodium chloride as
the drinking fluid. At the end of the study, the ani-
mals were exsanguinated through the abdominal
aorta, and blood pH, Pco2, and plasma electrolyte
concentrations were measured.
Group 11. Potassium adaptation. Twenty normal
rats were fed 10 glday of normal rat chow diet (see
composition below); this diet was supplemented
with 18.5 mEq of potassium (as potassium chloride)
per 10 g of the diet daily. Ten rats were given 0.45%
sodium chloride as drinking fluid, and the remaining
ten rats ingested water. Both groups were allowed
to stabilize on this diet for 10 days before collec-
tions were started. Three 24-hour urine collections
were obtained, and five animals in each group were
injected with BEA and five were injected with sa-
line. Three additional 24-hour urine collections
were obtained after BEA injection. In the end of the
study, the rats were anesthetized and exsan-
guinated through the abdominal aorta.
Analytical methods. GFR, blood and urinary
electrolyte measurements, and statistical analyses
were performed as previously described by us [3].
The titratable acidity was assessed by the amount of
0.1 N sodium hydroxide used to titrate 1 ml of urine
from urine pH up to 7.4. Ammonia was measured
by the formalin titrimetric method of Cunarro and
Weiner [4]. Plasma and urine osmolalities were
measured with a vapor pressure osmometer (Wes-
cor, mc). The nonelectrolyte solute (NES) in the
urine was calculated from the equation: NES = os-
molality — (1.84 x sodium + 2 x potassium), where
sodium and potassium represent the concentration
of these electrolytes in the urine [5].
The diets used in this study were obtained from
ICN Nutritional Biochemical Division, Inter-
national Chemical and Nuclear Co., Cleveland,
Ohio. The sodium-free diet contained the following
composition per 10 g of the diet: 3.04 mEq of cal-
cium, 1.77 mEq of chloride, 2.4 mEq of potassium,
0.98 m phosphorus, and small amounts of other
minerals. The potassium-free diet contained, per 10
g of the diet: 4.805 mEq of calcium, 0.6 Eq of chlo-
ride, 0.83 mEq of sodium, and 1.53 m phosphorus.
The normal rat chow diet used in this study had the
following composition per lOg of the diet: 2.77 mEq
of potassium, 1.77 mEq of sodium, and 1.77 mEq of
chloride. The sodium-, chloride-, and potassium-
free diet had the following composition per 10 g of
the diet: 6.4 mEq of calcium (as calcium carbonate
and calcium phosphate) and 1.2 m phosphorus;
potassium phosphate was added to this diet in an
amount of 2.9 mEq of potassium per lOg of the diet.
The values shown in the tables are the average of
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Fig. 1. Saggital section of kidneys of rats treated with bromoe-
thy/amine hydrobromide (BEA). Twenty-four hours after BEA
administration the papilla was normal, on gross mspection, but
showed definite evidence of necrosis on microscopic examina-
tion (lower panel) (see text). Two months after BEA adminis-
tration the papilla has sloughed off (upper panel).
two to three collections. Data are presented as
mean SEM.
Results
Morphologic studies. Figure 1 shows the gross
morphology of kidneys of BEA-treated rats. Twen-
ty-four hours after BEA administration, the papilla
did not show, on gross inspection, obvious signs of
necrosis, and it was not separated from the renal
medulla (Fig. 1, lower panel). No evidence of hy-
dronephrosis was present in these animals. The up-
per panel of Fig. 1 shows, for comparison, the kid-
ney of a rat removed 2 months following BEA ad-
ministration. The whole papilla had sloughed off; in
some animals it was seen lying free in the pelvis, but
no obvious evidence of hydronephrosis was demon-
strated in the few animals studied after 2 months.
The kidneys of two rats after 24 hours of BEA
administration were perfused in vivo, as previously
described by this laboratory, and were examined
under the transmission electron microscope [6].
The glomeruli, proximal tubules, and thick ascend-
ing limbs were normal. Careful examination of thick
ascending limbs of the deep nephrons failed to re-
veal any evidence of morphologic alteration. The
pathologic changes were present in the papilla and
were identical to those described by Hill et a! [2]; in
brief, the capillaries and thin limbs in the papilla
showed cytoplasmic and nuclear degeneration, and
there was congestion of capillaries with occasional
thrombosis. In some instances, the alterations in
the structure were so extensive as to preclude iden-
tification of these structures, that is, differentiation
between thin limbs and vessels. In some thin limbs
and capillaries, the basement membranes were de-
nuded from the cells. The cell of thin limbs showed
extensive degeneration with microvesicular altera-
tion of cytoplasm and presence of fibrin-like materi-
al in the lumen. The terminal collecting duct
showed focal areas of degeneration and necrosis,
but no dilation of the lumen was present. The inter-
stitial cells were also affected, showing definite evi-
dence of necrosis.
Hydropenic rats. Table 1 presents a summary of
the clearance data obtained in hydropenic BEA-
treated and sham rats. GFR was not significantly
different between the two groups. Urine flow and
fractional water excretion were significantly higher
in BEA-treated rats than they were in sham rats.
Fractional excretion of sodium was higher in BEA-
Table 1. Clearance data in hydropenic BEA-treated and sham ratsa
GFR
,nllmin
V
pJ/inin
V/GFR
%
FENa
%
FEK
%
FE1
%
C0smIGFR
%
Uosmh
mOsmlkg H20
UNES1'
mOsmlkg H20
UNCS x V UNES/UOSmK
pOsm/min %
BEA-treated
(N = 10) 1.01 29.6 2.8 1.50 18.5 2.1 4.0 441.6 279.3 7.1 64.5
P < NS 0.001 0.001 0.02 NS NS 0.02 0.001 0.001 NS NS
Sham
(N = 6) 1.23 5.8 0.5 0.25 23.1 0.9 2.4 1630.7 1187.2 5.3 70.0
a Abbreviations are defined: V, urine flow; V/GFR, fractional water excretion; UNES, urine nonelectrolyte solute; UNES x V, nonelec-
trolyte solute excretion.
These are baseline values.
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treated rats than it was in sham rats; fractional ex-
cretion of chloride also tended to be greater in
BEA-treated rats than it was in sham rats, but the
difference did not achieve statistical significance.
Fractional excretion of potassium was not different
between the two groups. Baseline urine osmolality
was significantly lower in the BEA-treated rats,
compared to sham rats. The nonelectrolyte solute
concentration in the urine was lower in the BEA-
treated rats than it was in sham rats. The relative
contribution of nonelectrolyte solute to the total
urine osmolality was the same in both groups. The
excretion of nonelectrolyte solute was not different
between the two groups.
Bicarbonate reabsorption and acid excretion.
Figure 2 shows urine-blood (U-B) Pco2 in BEA-
treated and in sham rats. At plasma bicarbonate
concentrations lower than 45 mEq/liter, U-B Pco2
was significantly lower in BEA-treated rats (BEA-
treated, 17.4 4.96, vs. sham, 37.8 3.83 mm Hg;
P < 0.02). Urine bicarbonate concentrations were
also lower in BEA-treated rats (BEA-treated, 54.2
5.91, vs. sham, 154.4 15.69 mEq/liter; P <
0.001). When the plasma bicarbonate was increased
above 45 mEq/liter in the BEA-treated rats, urine
bicarbonate increased from 54.2 5.91 to 144.0
7.36 mEq/liter, P < 0.001, and U-B Pco2 increased
from 17.4 4.96 to 34.0 2.74 mm Hg, P < 0.05.
The latter value of U-B Pco2 was not significantly
different than that of control.
Figure 3 plots bicarbonate reabsorption values
against plasma bicarbonate concentrations in Group
2. Observe that bicarbonate reabsorption is com-
plete at low plasma bicarbonate concentrations in
both groups; there is no difference either in the
splay of bicarbonate reabsorption or in maximal bi-
carbonate reabsorption between the two groups
(BEA, 32.7 0.53; and sham, 34.1 0.86 mEq/liter
GFR) at plasma bicarbonate concentrations of 45.3
1.23 and 44.0 0.88 mEq!liter in BEA-treated
and in sham rats. There was no difference in plasma
potassium, plasma Pco2, and fractional excretion of
chloride between BEA-treated and sham rats. GFR
was not different between BEA-treated and sham
rats (BEA-treated, 1.86 0.25, vs. sham, 2.44
0.24 ml/min). Fractional excretion of potassium
during bicarbonate loading was 49.9 3.02 in BEA-
treated and 53.4 3.63% in sham rats.
Table 2 presents data of urinary acidification dur-
ing sodium sulfate infusion in chronic acidotic
BEA-treated and sham rats treated with DOCA. At
comparable levels of acidosis, there was no dif-
ference in urine pH, ammonium excretion, titra-
table acid excretion, and net acid excretion. Before
sodium sulfate infusion, fractional excretion of so-
dium was higher in BEA-treated rats than it was in
sham rats (BEA-treated, 2.2 0.68, vs. sham, 0.6
0.13%, P < 0.05); fractional excretion of potas-
sium was not significantly different between the two
groups (BEA-treated, 26.0 3.82, vs. sham, 16.7
2.69%). During sodium sulfate infusion, there was
no difference in the fractional excretion of sodium
and potassium between BEA-treated and sham rats.
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Fig. 2. Urine-blood PCO2, in BEA (solid circles) and in sham rats
(open circles) during sodium bicarbonate (NaHCO)) administra-
tion.
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Fig. 3. Bicarbonate (HCO:3) reabsorption is plotted against
plasma bicarbonate for BEA (solid circles) and sham rats (open
circles).
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Fig. 4. Free water reabsorption is plotted against osmolar clear-
ance for BEA (solid circles and triangles) and sham rats (open
circles).
Urine concentration and dilution. Mean maximal
urine osmolality was 2303.1 163.16 mOsmlkg
H20 in the sham rats, 494.1 38.65 mOsm!kg H20
in the BEA-treated rats that received antidiuretic
hormone and were water restricted (P < 0.01), and
519.3 38.40 mOsmlkg H20 in BEA-treated rats
that received antidiuretic hormone but were not re-
stricted water (P < 0.001).
Figure 4 shows free water reabsorption (Tc1120
GFR) plotted against osmolar clearance for BEA-
treated rats infused with bicarbonate (group 1),
BEA-treated rats infused with 3% sodium chloride
and sham rats infused with bicarbonate (group 1).
Wallin et al demonstrated that in normal rats T2H20
measured during sodium bicarbonate or sodium
chloride loading was not significantly different, pro-
vided plasma chloride concentration and chloride
excretion did not change during bicarbonate loading
[7]. During sodium bicarbonate loading, there was
no difference in either plasma chloride concentra-
tion or chloride excretion between BEA-treated and
sham rats (plasma chloride, 99.7 9.41 and 98.6
0.93 mEq!liter and chloride excretion, 14.4 2.65
and 20.3 8.96 .tEq!min, in BEA and sham rats,
respectively). There was no difference in Tt11,0 in
the BEA rats measured during bicarbonate loading
or during sodium chloride loading. For this reason,
the data of Tc1120 in BEA rats measured during bi-
carbonate loading and sodium chloride were
pooled. Tc1120 was significantly lower in the BEA-
treated rats than it was in sham rats at all levels of
osmolar clearance (BEA-treated, y = 1.34 + 0.19x,
r = 0.73,P <0.001; sham,y = 1.36 + 0.36x, r =
0.93, P < 0.001). The slope of the two lines were
significantly different (P <0.001). Observe that dif-
ferences in Tc1120 between BEA-treated and sham
rats cannot be explained by the type of solution
used to increase solute excretion. In sham rats,
Tc112() was measured only during sodium bicarbonate
loading, and yet this parameter was greater than the
TH2O of BEA-treated rats infused either with so-
dium bicarbonate or with sodium chloride. There
was no difference in renal tissue concentrations of
sodium, potassium, and water between the two
groups. The mean nonurea solute concentrations in
BEA-treated and sham rats were, respectively, cor-
tex, 317.0 7.4 and 305.2 17.5; medulla, 368.3
27.1 and 395.8 19.5; and papilla, 591.7 45.9 and
716.0 73.1 mOsm!kg H20; P = NS). The mean
urine osmolality was significantly lower in BEA-
treated than it was in sham rats (612.0 116.2 vs.
1502.0 300.03 mOsm!kg H20, P < 0.02, respec-
tively).
Free water clearance (C1120) data in BEA-treated
and in sham rats are shown in Figure 5. There was
no difference in C1120 between the two groups (BEA-
treated, y = 2.5 0.50x; and sham, y = 1.4
0.49x; the slopes of these two lines were not signifi-
cantly different). The mean GFR in BEA-treated
and sham rats was 1.45 0.16 and 1.76 0.16 ml!
mm (NS). The mean urine osmolality was also not
different between the two groups (BEA-treated,
103.0 4.97; and sham, 103.4 4.79 mOsm/kg
H20).
Table 2. Urinary acidification in chronically acidotic BEA-treated and sham rats during sodium sulfate infusiona
GFR
tn//mm
V
gi/min
P11c0
inEqI/iter Blood pH Urine pH
TAEx
pEq/min
NH4Ex
p.Eq/min
NH4EXJGFR
Eq/ml GFR
Net acid
ExIGFR
p.Eq/ml GFR
FENa
%
FEK
%
BEA-treated
(N = 6) 1.56 66.6 19.0 1.1 3.1 1.97 2.6 4,6 65.0
P NS <0.01 NS NS NS NS NS NS NS NS NS
Sham (N = 6) 1.96 39.0 17.6 7.22 5.30 1.1 3.1 1.61 2.1 4.6 45.0
Abbreviations are defined: V, urine fiow; TA, titratable acid; Ex = excretion.
U-0
0
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Sodium restriction. There was no difference in
urine volume between the two groups in the control
days; following BEA injection, urine volume was
significantly higher in BEA-treated than it was in
sham rats (24.7 2.4 vs 9.4 1.3 mllmin, P <
0.001). Sodium excretion was not different between
the two groups in the control days; in the experi-
mental period, BEA-treated rats showed a signifi-
cant natriuresis, whereas the sham rats remained in
sodium balance (Fig. 6). The cumulative sodium ex-
cretion per 3 days was significantly higher in the
BEA-treated, compared to sham rats (Table 3).
There was no difference in daily excretion or in cu-
mulative excretion of potassium or chloride be-
tween the two groups (Table 3). There was no dif-
ference in BUN, PRA, and plasma electrolyte con-
centration between the two groups (Table 3).
Sodium and chloride restriction. Since the anion
(probably phosphate) accompanying the excretion
of sodium was not determined in the previous stud-
ies, an additional group of animals was studied in
which both sodium and chloride were restricted.
Figure 7 shows a summary of the data obtained in
this group. There was no difference in any parame-
ter between the two groups of rats in the control
days. During the experimental days, the BEA-
treated rats had a significant increase in sodium and
chloride excretion, whereas sham rats remained in
sodium and chloride balance. Table 3 shows that
cumulative excretion of sodium and chloride in the
experimental days were significantly greater in
BEA-treated rats than they were in sham rats. The
excretion of potassium was not different between
the two groups. Calcium excretion remained un-
changed in sham rats and increased significantly in
the BEA-treated rats on experimental days 1 and 2
as compared to control day 3 (paired analysis). As
8 10 12 14 16 18 20 22
V/GFR, %
Fig. 5. Free water clearance is plotted against urine flow in BEA
(solid circles) and in sham rats (open circles).
Table 3.Cumulative electrolyte excretion (tEqI72 hr) in BEA-treated and sham ratsa
Low-sodium diet Low- sodium chioride diet
BEA-treated Sham BEA-treated Sham
(N= 5) P (N=6) (N=5) P (N=6)
NaEx 788.0 284.2 <0.02 46.0 5.0 1788.8 380.3 <0.01 140.8 32.2
CI Ex 3906.8 203.7 NS 3888.0 263.6 1430.7 245.5 <0.001 89.8 22.7
KEx 4495.2 401.7 NS 5181.5 379.6 5093.8 653.9 NS 5073.7 6266.5
CaEx — — 153.6 16.1 <0.01 73.4 15.8
BUN,rng/lOOm/ 24.0 7.0 NS 17.0 0.9 49.9 12.8 <0.01 13.7 0.3
PNa,mEqlliter 143.7 1.7 NS 144.5 0.5 136.3 6.0 NS 146.0 7.4
P,mEq/liter 4.3 0.4 NS 4.4 0.5
Pi,mEqIliter 103.0 0.6 NS 104.0 0.8 101.8 4.8 NS 106.3 11.0
Po,mEqIliter 22.4 1.0 NS 20.7 1.0 19.9 1.0 <0.01 22.0 1.7
Pca,mEq/liter — — 3.9 0.1 <0.01 4.4 0.1
PRA,ngAllhr 29.0 14.0 NS 26.0 10.0 — —
a Abbreviations are defined: Ex, excretion; Al, angiotensin I.
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Fig. 7. Sodium chloride, potassium, and calcium excretion in
BEA (open bars) and in sham rats (cross-hatched bars) receiving
a zero' sodiu,n and chloride intake. Sodium and chloride ex-
cretion in 3 experimental days were significantly higher than they
were in control. The asterisk indicates the values which were
significantly different than the third control day.
compared to sham rats, calcium excretion was
greater in BEA-treated rats during experimental
days 1 and 2. The cumulative calcium excretion was
significantly greater in the BEA-treated rats than it
was in sham rats (Table 3). BEA-treated rats lost
9.9 0.24% of their body weight over the 3 experi-
mental days; in the sham rats, body weight was un-
changed (+1.0 0.4%, P < 0.001). BUN was sig-
nificantly greater in BEA-treated than it was in
sham rats. There was no difference in plasma elec-
trolyte concentrations except for a lower plasma
calcium and plasma bicarbonate in BEA-treated
rats than those in sham. The mean urine osmolality
after BEA injection was significantly lower in BEA-
treated rats than it was in sham rats (BEA, 582.7
36.8, vs. sham 1423.5 109.49 mOsm kg!H20, P <
0.001). Urine volume was significantly higher in the
BEA-treated than it was in sham rats (27.9 1.50
vs. 7.1 0.83 ml, P <0.001).
Potassium restriction. There was no difference in
sodium or chloride excretion in control and in ex-
perimental periods between the two groups (Fig. 8,
Table 4). Potassium excretion in the control period
was not different between the two groups. Follow-
ing BEA injection, potassium excretion increased
significantly above control values (the values ob-
tained during experimental days I and 2 were higher
than control day 3). In rats injected with saline, po-
tassium excretion remained unchanged. Potassium
excretion was higher in BEA-treated rats than it
was in sham rats only on experimental day 1; cu-
mulative potassium excretion in the experimental
days was significantly greater in the BEA compared
to sham rats (Table 4).
There was no difi'erence in calcium excretion be-
tween the two groups in the control days. Following
BEA injection, calcium excretion increased signifi-
cantly; the values observed on experimental days I
and 2 and cumulative calcium excretion were signif-
icantly higher in BEA-treated rats than they were in
sham rats. Plasma potassium was significantly
lower in BEA-treated rats than it was in sham rats;
Table 4. Cumulative electrolyte excretion (rEq/72 hr) in BEA-treated and sham rats°
Zero-potassium diet Potassium loading
BEA-treated Sham
(N = 5) P (N = 5)
BEA-treated
(N = 6) P
Sham
(N = 9)
NaEx
Cl Ex
K Ex
CaEx
BUN,Mg/IOOml
P\,mEq/liter
PK,mEq/liter
PCI, mEqiliter
mEq/liter
P,,,mEq/liter
10.282.0 1,018.8 NS I l.0l8.6 2,168.1
11,496.2 1 .147.7 NS 12,021.0 2,004.8
308.4 57.3 <0.05 157.4 19.6
208.0 31.9 <0.05 107.5 21.8
15.1 0.5 NS 15.6 0.4
50.5 1.4 NS 153.5 2.8
2.0 1.2 <0.05 2.9 0.3
92.2 1.7 NS 95.5 3.7
36.0 2.5 NS 29.4 2.5
5.2 0.3 NS 4.9 0.4
18,689.5 4,625.7 NS
46,382.2 9,789.0 NS
31,420.7 4,468.5 <0.02
183.3 49.6 NS
24.0 3.8 NS
154.4 4.0 NS
6.7 1.4 <0.05
121.6 6.5 NS
—
3.4 0.2 NS
10,187.2 2,800.6
51,060.3 9,788.9
47,131.7 3,252.9
197.7 20.4
27.0 2.3
153.4 3.7
3•5 0.6"
116.3 4.5
—
3.9 0.2
Ex is excretion.
"This was measured in three animals only.
fl PN Sham
P <0.001
P <0.001
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there was no difference in other plasma electrolyte
concentrations or BUN between the two groups.
Potassium adaptation. This group of rats were di-
vided in two: one had water as drinking fluid, the
other had 0.45% sodium chloride as the drinking
fluid. The reason for giving sodium chloride as the
drinking fluid was to prevent changes in distal deliv-
ery of sodium (secondary to volume contraction
consequent to sodium wastage). Since there was no
difference between the two groups (saline drinking
vs. water drinking), the results of the two groups
were combined and presented as a single group. In
the BEA-treated group, three animals died by ex-
perimental day 3 (one in the saline-drinking and two
in the water-drinking group), and one animal was
excluded for technical reasons. In the control
group, one animal died on experimental day 3. Fig-
ure 9 shows daily electrolyte excretion in BEA-
treated and in sham rats. There was no difference in
sodium, potassium, chloride, and calcium excretion
between the two groups in the control days. Potas-
sium excretion was significantly lower in BEA-
treated than it was in sham rats on experimental
days 1 and 2. On day 3, potassium excretion was
P <0.01
P <0.001
Days 1 Days
BEA
Fig. 9. Sodium, chloride, potassium, and calcium excretion in
BEA (open bars) and in sham rats (cross-hatched bars) receiving
a high potassium diet. The asterisk indicates the values which
were different than those obtained on the third control day.
1 2 3 1 2
Days I Days
B EA
not different between the two groups: observe,
however, that three BEA-treated rats had died by
experimental day 3, probably as a consequence of
hyperkalemia, since potassium excretion was sig-
nificantly lower in BEA-treated than it was insham
rats. In this group, calcium excretion was not dif-
ferent between the two groups. Table 4 shows the
cumulative electrolyte excretion in B EA-treated
and in sham rats that survived 72 hours, Cumulative
potassium excretion was significantly lower in
BEA-treated than it was in sham rats. There was no
difference in sodium, chloride, bicarbonate, BUN,
or plasma creatinine concentrations between the
two groups. Plasma potassium concentrations were
significantly higher in BEA-treated rats than they
were in sham rats. Plasma creatinine concentrations
were not significantly different between BEA-
treated and sham rats (BEA-treated, 0.55 0.03,
vs. sham, 0.47 0.03 mgIlOO ml).
Discussion
The present studies demonstrate that one single
injection of BEA to rats uniformly results in the de-
velopment of a concentrating defect and a wastage
of sodium, chloride, potassium, and calcium. Also
observed were a normal diluting capacity, normal
z
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Fig. 8. Sodium chloride, potassium and calcium excretion in
BEA (open bars) and in sham rats (cross-hatched bars) receiving
a ''zero' potassium intake. The asterisk indicates the values
which were different than those obtained on the third control
day.
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bicarbonate reabsorption, and distal acidification,
and impaired adaptation to a high-potassium diet.
BEA administration results in damage to the jux-
tamedullary nephron and in particular to the termi-
nal collecting duct [1, 21. It is therefore impossible
to determine whether the abnormalities which de-
veloped after its administration result solely from
alterations in papillary collecting duct transport or
from both changes in papillary collecting duct func-
tion and selective loss of juxtamedullary nephrons
[5, 8—10]. Regardless of the extent of involvement of
the juxtamedullary nephrons, the BEA model of
papillary necrosis represents an easily induced ani-
mal counterpart of human papillary necrosis (a dis-
ease which involves both the juxtamedullary neph-
ron and papillary collecting duct) and should provide
great insight into the functional abnormalities
caused by this lesion.
The present study demonstrates a defect in maxi-
mal urine osmolality and in free water reabsorption;
it is thus in agreement with similar findings in papil-
lectomized rats and dogs [11—16]. The concentrating
defect induced by BEA could result from the dis-
ruption of anatomic integrity of the medulla, im-
paired response of the collecting duct to ADH,
wash out of the medullary solute gradient by the in-
creased medullary plasma flow observed in this
model [18], and impaired function of the thick
ascending limb [14, 17]. The finding of normal free
water clearance during water diuresis argues against
a major defect in thick ascending limb function, and
the normal nonurea solute concentration suggests
that the increased medullary plasma flow demon-
strated in this model by Solez et al [18] does not
play a role in the concentrating defect of this model
[19]. Thus, it is likely that the concentrating defect
induced by BEA administration is the result of im-
paired collecting duct response to antidiuretic
hormone.
Previous studies of papillectomized animals have
yielded conflicting results regarding the role of the
papilla in the formation of maximal urine osmolality
and free water reabsorption [12, 14—16]. The extent
of the papillectomy likely accounts for the different
results, The greater the extent of the papillectomy,
the more likely it is for the medulla to be involved,
hence the impairment of both maximal urine os-
molality and free water reabsorption. The finding of
impaired free water reabsorption in the present
study suggests that the BEA model may involve
some inner medullary structure [14].
The present study, as well as that of Martinez-
Maldonado and Opava-Stitzer [14], has failed to dis-
close a defect in urinary dilution. Since the collect-
ing duct has been shown to participate in urinary
dilution [20, 21] (in Brattleboro rats urine osmolality
was reduced from 97 in the cortical tubule to 64
mOsmlkg H20 in the final urine), the failure to de-
tect a defect in urinary dilution may be due to the
fact that in our experiments the collecting duct
likely did not participate in the process of dilution
since the mean urine osmolality in both the control
and BEA-treated rats was not below 100 mOsm/kg
H20.
Previous studies have examined the transport of
various electrolytes in papillectomized rats. Most of
these studies were performed in animals with se-
vere reduction of the nephron mass caused by re-
moval of the contralateral kidney [22, 23]. These
studies therefore do not allow assessment of the
role of the papillary structures themselves in the ab-
sence of renal insufficiency in electrolyte transport.
In the presence of a normal contralateral kidney,
the papillectomized kidney has been shown to have
either normal or increased fractional sodium excre-
tion as compared to the normal kidney [12, 14]. It is
difficult to determine to what extent the increase in
fractional sodium excretion is due to the loss of
papillary structures or to the reduction in GFR. Pre-
vious studies have not examined the ability of the
papillectomized kidney to adapt to a low-sodium-
chloride diet. The results of the present study demon-
strate that BEA'treated rats failed to adapt to a low-
sodium chloride diet, and they wasted sodium chlo-
ride. BEA-treated rats also wasted sodium when in-
gesting a normal sodium chloride diet. The sodium
wastage of BEA-treated rats was observed in the
absence of any detectable change in GFR. The fail-
ure of BEA to conserve sodium may be due either
to impaired collecting duct transport or a selective
loss of juxtamedullary nephrons with a consequent
increase in single nephron GFR in the remaining
nephrons [5, 8—10, 24]. Since free water clearance
was normal in the BEA-treated rats, it is reasonable
to assume the sodium reabsorption in the thick as-
cending limb to have been normal, and therefore the
defect in sodium handling must be distal to the thick
ascending limb. Thus, if single nephron GFR were
elevated owing to the loss of deep nephrons, the in-
creased delivery of sodium to a damaged collecting
duct would likely result in sodium wastage.
The role of the papillary structure in urinary acid-
ification has not been studied in detail. In the ham-
ster, the papillary collecting duct has been shown to
participate in the lowering of the urine pH [25]. In
unilaterally papillectomized rats with renal failure
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(caused by removal of the contralateral kidney), the
minimal urine pH achieved during ammonium chlo-
ride administration was not different than that ob-
served in controls or in rats with partial nephrecto-
my [221. Total acid and ammonium excretion were
lower in papillectomized rats than they were in the
other two groups [221. In that study, the role of pap-
illary structures themselves in urinary acidification
is difficult to assess owing to the presence of renal
failure. The present study demonstrates that rats
with papillary necrosis are able to lower urine pH,
increase ammonium excretion, and raise the U-B
Pco2 administration to the same level as that seen in
normal animals [261. In highly alkaline urine, Pco2
is determined both by urine bicarbonate concentra-
tion and by hydrogen ion secretion [261. Acid-
ification, in highly alkaline urine, can be assessed
by the urinary Pco2, provided one corrects for the
influence of urine bicarbonate concentration. These
observations suggest that the papillary structures
are not essential for the achievement of maximal
urinary acidification. These findings do not exclude
the possibility that the papillary structures may, un-
der normal circumstances, participate in the proc-
ess of urinary acidification.
The present study showing calcium wastage in
rats with papillary necrosis suggests that the papil-
lary structures are important in the regulation of
calcium excretion. Only one previous study has ex-
amined the role of papillary structures in calcium
reabsoprtion [231. That study demonstrated that
papillectomized rats with renal failure have a great-
er calciuria than do rats with partial nephrectomy.
The calciuria of BEA-treated rats can be explained
either by damage of the terminal nephron, which has
been suggested to be the final regulator of calcium
excretion, or by loss of deep nephrons which have
been shown to have a greater reabsorptive capacity
for calcium than do the superficial nephrons [27, 28].
Thus, the mechanism for the calciuria would be
similar to the one outlined for sodium wastage.
Previous studies have examined the ability of
papillectomized rats with renal failure to excrete an
acute load of potassium [22]. In the present study,
we studied renal potassium handling in papillary ne-
crosis in the absence of renal failure. Our observa-
tions demonstrate that under normal conditions
BEA-treated rats excreted potassium at the same
level as that seen in normal animals in response to
bicarbonate administration and sodium sulfate in-
fusion. In the presence of potassium deprivation,
BEA-treated rats wasted potassium and developed
hypokalemia. In the presence of a high-potassium
diet, BEA-treated rats had significantly lower po-
tassium excretions than did controls. Alterations in
collecting duct transport or selective loss of the jux-
tamedullary nephrons may explain both types of ab-
normalities in potassium handling [8, 9, 29-31]. Se-
lective loss of juxtamedullary nephrons could lead
to enhanced distal sodium delivery in superficial
nephrons, with consequent increased sodium-po-
tassium exchange and, hence, hypokalemia. Alter-
natively, the hypokalemia could be explained by
damage of the papillary collecting duct, which has
been shown to reabsorb significant amounts of po-
tassium during potassium deprivation but not under
normal circumstances [91. The impaired potassium
excretion by the BEA-treated rats during potassium
loading is in perfect agreement with the suggestion
that the papillary collecting duct is the site respon-
sible for adaptation to a high-potassium diet [9, 25].
It must be emphasized, however, that loss of jux-
tamedullary nephrons can also explain these obser-
vations since it has been shown that the descending
thin limbs of the deep nephrons exhibit potassium
secretion, which is enhanced by chronic potassium
loading [30, 31]. It is thus possible that damage of
the deep nephrons could result in impaired potas-
sium excretion in the BEA model.
Conclusion. Papillary necrosis is associated with
impaired urinary concentration, normal urinary di-
lution and acidification, sodium, chloride, and cal-
cium wastage, potassium wastage during potassium
deprivation, and impaired potassium excretion dur-
ing potassium loading. These data indicate that the
papillary structures are not essential for maximal
urinary acidification: these abnormalities in elec-
trolyte transport may arise either as the con-
sequence of alterations in papillary collecting duct
transport or from selective loss of the juxtamedul-
lary nephrons.
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